Science ❯ Biotechnology ❯ Drug Development ❯ Clinical Trials

Cancer Drugs

ImmunityBio Extends Rally to 52-Week High on Anktiva Sales, Saudi Approval and Trial Progress

Early 2026 momentum reflects surging Anktiva revenue alongside Saudi clearance opening a new market.